Thought
Leadership

AI has become deeply embedded in medical imaging. Specialized algorithms can now detect intracranial bleeds, measure lung nodules, and summarized clinical documentation into actionable data. The diagnostic capabilities are real, but so is the complexity. As the number of these AI tools grow, so does the technical overhead required to manage them. Clinicians are often left to manually interpret imaging orders, review patient context, and determine which studies should be sent

Artificial intelligence in radiology has reached a turning point. Healthcare executives and informatics leaders are no longer asking if AI can analyze imaging data, they are asking how to measure its return on investment (ROI). With hundreds of FDA-cleared algorithms on the market, health systems often find themselves facing "AI fatigue." Purchasing individual licenses for disparate point solutions creates complex vendor management challenges, high software maintenance costs,

The promise of artificial intelligence in medical imaging is no longer a matter of future speculation; it is a present-day reality. From automated triage of acute cases to automated organ segmentation, AI algorithms offer unprecedented opportunities to accelerate care. Yet, for many radiology leaders and clinical informatics teams, a significant disconnect remains between purchasing AI capabilities and realizing their full clinical utility in daily operations. Algorithms that

In acute and high-volume clinical settings, minutes matter. Whether evaluating a suspected Large Vessel Occlusion (LVO), scoring Coronary Artery Calcium (CAC), or identifying subtle pulmonary nodules, clinical teams need reliable diagnostic data delivered with zero friction. Yet, many health systems encounter what industry leaders call the AI execution gap: the disconnect between an algorithm generating an output and that output being utilized in a clinical pathway. Bridging